ストックスクリーナーアプリを入手
12.59
2.06%
-0.265
Tenax Therapeutics Inc (TENX) 最新ニュース
Is Tenax Therapeutics Inc. stock near bottom after declineWeekly Trend Report & Low Volatility Stock Suggestions - ulpravda.ru
What is the fair value of Tenax Therapeutics Inc. stock nowEarnings Performance Report & Real-Time Buy Signal Notifications - ulpravda.ru
Precision Trading with Tenax Therapeutics Inc. (TENX) Risk Zones - Stock Traders Daily
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Tenax Therapeutics Inc. (TENX) Affects Rotational Strategy Timing - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics (TENX) Price Target Increased by 12.22% to 25.76 - Nasdaq
Will Tenax Therapeutics Inc. stock see insider buying2025 Trading Recap & Verified High Yield Trade Plans - DonanımHaber
Is Tenax Therapeutics Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - DonanımHaber
Roth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX) - The Globe and Mail
Is Tenax Therapeutics Inc. stock supported by strong cash flowsMarket Movers & Low Drawdown Investment Ideas - DonanımHaber
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Can Tenax Therapeutics Inc. stock beat market expectations this quarter2025 Technical Patterns & Safe Capital Growth Stock Tips - Улправда
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Guggenheim Maintains Tenax Therapeutics (TENX) Buy Recommendation - Nasdaq
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target By Investing.com - Investing.com Canada
[8-K] TENAX THERAPEUTICS, INC. Reports Material Event | TENX SEC FilingForm 8-K - Stock Titan
Tenax Therapeutics (TENX) Updates on Clinical Trials and New Ini - GuruFocus
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target - Investing.com
Tenax Therapeutics level trial on track to complete enrollment in H1 2026 - marketscreener.com
Tenax Therapeutics Confirms Enrollment Target for LEVEL Study; Initiates LEVEL-2 Phase 3 Study for TNX-103 - Quiver Quantitative
Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026 - TradingView — Track All Markets
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment - The Manila Times
Heart failure drug trials expand as Tenax starts second Phase 3 study - Stock Titan
Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim - Investing.com Canada
Tenax Therapeutics (TENX): Analyst Raises Target Price to $25 | - GuruFocus
Growth Report: Is YETI stock recession proof2025 Buyback Activity & Safe Entry Zone Tips - moha.gov.vn
Discipline and Rules-Based Execution in TENX Response - Stock Traders Daily
What analysts say about Tenax Therapeutics Inc stockCovered Call Writing & Build Winning Strategies With Zero Cost - earlytimes.in
JANUS HENDERSON GROUP PLC Acquires Additional Shares in Tenax Therapeutics Inc - GuruFocus
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 2,500 Shares - MarketBeat
Tenax Therapeutics director Rich Stuart buys $50,792 in stock By Investing.com - Investing.com South Africa
Tenax Therapeutics director Rich Stuart buys $50,792 in stock - Investing.com
Officer/Dir Rich Buys 5,000 ($50.8K) Of Tenax Therapeutics Inc [TENX] - TradingView — Track All Markets
TENAX Therapeutics CMO Stuart Rich Acquires 5,000 Shares - TradingView — Track All Markets
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 1,500 Shares - MarketBeat
Officer/Dir Rich Buys 5,000 ($45.6K) Of Tenax Therapeutics Inc [TENX] - TradingView
What technical signals suggest for Tenax Therapeutics Inc. stock2025 Macro Impact & Short-Term High Return Strategies - Newser
Behavioral Patterns of TENX and Institutional Flows - Stock Traders Daily
Why Tenax Therapeutics Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Financial Analysis: Mainz Biomed (NASDAQ:MYNZ) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
What analysts say about Tenax Therapeutics Inc. stockMean Reversion Trades & Market-Leading Growth Rates - earlytimes.in
Tenax Therapeutics to Participate in Upcoming Investor Conferences - Investing News Network
Tenax Therapeutics (Nasdaq: TENX) plans Dec. 2 and 4 fireside chats at Evercore, Piper - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
(TENX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
GIORDANO CHRISTOPHER THOMAS Insider Trades - Nasdaq
Is Tenax Therapeutics Inc. stock a safe buy before earningsEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999 By Investing.com - Investing.com Nigeria
5.77%
大文字化:
|
ボリューム (24 時間):